In addition, in this study, the co-expression of S100A4 and CA19.9 in patients with stage III–IV PC was higher than that in patients with stage I–II PC, while that in PC patients in the highly differentiated group was lower than that in the moderately and low-differentiated group. This evidence concerns the gene S100A4 and pachyonychia congenita.